MedTrace Logo

Dietary Supplementation of Lactogyn in Women With Bacterial Vaginosis

NCT03601429 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 166

Last updated 2019-04-29

No results posted yet for this study

Summary

The objective of the study is to determine clinical efficacy of Lactogyn (Lactobacillus Crispatus, L. brevis, L.acidophilus) in prevention of recurrent BV

Conditions

  • Bacterial Vaginosis

Interventions

DIETARY_SUPPLEMENT

Lactogyn

capsules

DIETARY_SUPPLEMENT

Placebo

capsules

Sponsors & Collaborators

  • Vesale Pharmaceutica

    lead INDUSTRY

Principal Investigators

  • Karl Richir · Vesale Pharma

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-08-31
Completion
2018-08-31

Countries

  • Ukraine

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03601429 on ClinicalTrials.gov